Lupin launches generic diabetes drug in US after USFDA approval
Summary
Lupin launches generic dapagliflozin and metformin tablets in US after USFDA approval, offering a bioequivalent alternative to Xigduo XR.
Description
Lupin launches generic dapagliflozin and metformin tablets in US after USFDA approval, offering a bioequivalent alternative to Xigduo XR.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source